Edition:
India

Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

125.03USD
22 Jul 2016
Change (% chg)

$-0.12 (-0.10%)
Prev Close
$125.15
Open
$125.12
Day's High
$125.35
Day's Low
$124.65
Volume
2,174,557
Avg. Vol
2,496,382
52-wk High
$126.07
52-wk Low
$81.79

JNJ.N

Chart for JNJ.N

About

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care,... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $343,913.09
Shares Outstanding(Mil.): 2,750.64
Dividend: 0.80
Yield (%): 2.56

Financials

  JNJ.N Industry Sector
P/E (TTM): 23.29 36.47 37.34
EPS (TTM): 5.37 -- --
ROI: -- 14.88 14.14
ROE: -- 15.96 15.35

J&J unit's former executives convicted of unapproved marketing

Two former executives of Acclarent Inc, a medical device company bought by Johnson & Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use.

21 Jul 2016

J&J unit's former execs convicted of unapproved marketing

July 19 Two former executives of Acclarent Inc, a medical device company bought by Johnson & Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use.

21 Jul 2016

Johnson & Johnson raises 2016 forecast, shares touch record high

Johnson & Johnson on Tuesday raised its full-year 2016 sales and earnings forecasts and reported quarterly results that beat estimates, helped by strength in its prescription drugs business.

19 Jul 2016

UPDATE 4-Johnson & Johnson raises 2016 forecast, shares touch record high

July 19 Johnson & Johnson on Tuesday raised its full-year 2016 sales and earnings forecasts and reported quarterly results that beat estimates, helped by strength in its prescription drugs business.

19 Jul 2016

BRIEF-Johnson & Johnson posts Q2 earnings of $1.43/share

* Q2 earnings per share view $1.68 -- Thomson Reuters I/B/E/S

19 Jul 2016

J&J quarterly sales rise 3.9 pct

July 19 Diversified healthcare company Johnson & Johnson reported a 3.9 percent increase in second-quarter sales, helped by strength in its pharmaceuticals business.

19 Jul 2016

TPG to acquire surgical tools maker Beaver-Visitec

TPG Capital LP, one of the world's largest private equity firms, has agreed to acquire Beaver-Visitec International, a U.S. maker of tools used in eye surgery, from buyout firm RoundTable Capital Partners.

19 Jul 2016

TPG to acquire surgical tools maker Beaver-Visitec

July 18 TPG Capital LP, one of the world's largest private equity firms, has agreed to acquire Beaver-Visitec International, a U.S. maker of tools used in eye surgery, from buyout firm RoundTable Capital Partners.

19 Jul 2016

BRIEF-Johnson & Johnson announces completion of Vogue International deal

* Johnson & Johnson announces completion of acquisition of Vogue International Llc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

19 Jul 2016

BRIEF-Johnson & Johnson sets quarterly cash dividend of $0.80 per share

* Sets quarterly cash dividend of $0.80 per share Source text for Eikon: Further company coverage:

19 Jul 2016

Earnings vs. Estimates